N-Methyl palbociclib

CAS : 571189-51-0

Ref. 3D-WXA18951

Informations sur le produit

• Nom: N-Methyl palbociclib
• Synonymes: 6-Acetyl-8-cyclopentyl-5-methyl-2-[[5-(4-methylpiperazin-1-yl)pyridin-2-yl]amino]-8H-pyrido[2,3-d]pyrimidin-7-one, Pyrido[2,3-d]pyrimidin-7(8H)-one, 6-acetyl-8-cyclopentyl-5-methyl-2-[[5-(4-methyl-1-piperazinyl)-2-pyridinyl]amino]-, 6-Acetyl-8-cyclopentyl-5-methyl-2-[[5-(4-methyl-1-piperazinyl)-2-pyridinyl]amino]pyrido[2,3-d]pyrimidin-7(8H)-one

Description

N-Methyl palbociclib is a compound that exhibits hepatocyte growth factor (HGF) neutralizing activity. It acts by binding to HGF and preventing its interaction with its receptor, leading to the inhibition of HGF-induced signaling pathways. N-Methyl palbociclib has been shown to inhibit the proliferation of human hepatocytes in vitro and has potential applications in the field of Life Sciences. Additionally, it has cytotoxic effects on various cell types, including those expressing epidermal growth factor (EGF)-like and neurotrophic factors receptors. This compound also exhibits inhibitory effects on interleukin-6 (IL-6) signaling, which plays a crucial role in inflammation and immune responses. Overall, N-Methyl palbociclib shows promising potential as a therapeutic agent targeting multiple pathways involved in cell growth and signaling.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 461.6 g/mol
• Formule: C₂₅H₃₁N₇O₂
• Degré de pureté: Min. 95%